Status:
COMPLETED
Electroretinogram in Autistic Spectrum Disorders
Lead Sponsor:
Great Ormond Street Hospital for Children NHS Foundation Trust
Collaborating Sponsors:
Flinders University
Yale University
Conditions:
Autism Spectrum Disorder
Eligibility:
All Genders
4-25 years
Brief Summary
This study aims to find out the incidence of a reduced light adapted electroretinogram (ERG) b-wave amplitude in children with a diagnosis of Autism Spectrum Disorders (ASD).
Detailed Description
Autism Spectrum Disorder (ASD) is a neurodevelopmental condition which becomes apparent as children grow. Children with ASD are slow to develop language and have problems interacting socially with oth...
Eligibility Criteria
Inclusion
- cohort 1: individuals with diagnosis ASD with an IQ measure exceeding 85
- cohort 2: typically developed controls without diagnosis of ASD
Exclusion
- a history of eye disease or treatment or seizure medicines that may alter retinal function
Key Trial Info
Start Date :
September 3 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 3 2020
Estimated Enrollment :
177 Patients enrolled
Trial Details
Trial ID
NCT03422016
Start Date
September 3 2018
End Date
April 3 2020
Last Update
January 11 2022
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Yale University
New Haven, Connecticut, United States, 06520
2
Flinders University
Adelaide, South Australia, Australia
3
Swinburne University of Technology
Melbourne, Australia
4
Great Ormond Street Hospital for Children NHS Trust
London, United Kingdom, WC1N 3JH